Zentek Ltd. (NASDAQ:ZTEK) Short Interest Update

Zentek Ltd. (NASDAQ:ZTEKGet Free Report) was the target of a large decline in short interest in February. As of February 28th, there was short interest totalling 148,000 shares, a decline of 25.1% from the February 13th total of 197,500 shares. Based on an average daily volume of 45,800 shares, the days-to-cover ratio is currently 3.2 days. Currently, 0.2% of the shares of the stock are short sold.

Zentek Stock Down 0.2 %

NASDAQ ZTEK opened at $0.92 on Friday. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.83 and a quick ratio of 1.48. The company’s 50 day simple moving average is $1.05 and its 200 day simple moving average is $0.95. Zentek has a 12 month low of $0.50 and a 12 month high of $1.34. The company has a market capitalization of $95.76 million, a P/E ratio of -13.11 and a beta of 1.30.

Zentek (NASDAQ:ZTEKGet Free Report) last released its earnings results on Wednesday, February 12th. The company reported ($0.01) EPS for the quarter. Zentek had a negative return on equity of 58.13% and a negative net margin of 16,555.32%.

Institutional Investors Weigh In On Zentek

A number of large investors have recently made changes to their positions in ZTEK. Two Sigma Securities LLC acquired a new stake in shares of Zentek during the fourth quarter valued at approximately $31,000. Anson Funds Management LP acquired a new stake in shares of Zentek during the fourth quarter valued at approximately $145,000. Finally, Scotia Capital Inc. raised its holdings in shares of Zentek by 5.7% during the fourth quarter. Scotia Capital Inc. now owns 958,771 shares of the company’s stock valued at $867,000 after acquiring an additional 51,744 shares during the period. Institutional investors and hedge funds own 0.77% of the company’s stock.

Zentek Company Profile

(Get Free Report)

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.

Further Reading

Receive News & Ratings for Zentek Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zentek and related companies with MarketBeat.com's FREE daily email newsletter.